Articles

Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V

Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Austria
Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Austria;Ludwig Boltzmann Cluster Oncology, Vienna, Austria;Department for Companion Animals and Horses, Clinic of Internal Medicine and Infectious Diseases, University of Veterinary Medicine Vienna, Austria
Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Austria
Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Austria
III. Medizinische Klinik, Universitätsmedizin Mannheim, Mannheim, Germany
Guy’s Hospital, Division of Clinical Haematology, London, UK
Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Austria;Ludwig Boltzmann Cluster Oncology, Vienna, Austria;Department for Companion Animals and Horses, Clinic of Internal Medicine and Infectious Diseases, University of Veterinary Medicine Vienna, Austria
Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Austria;Ludwig Boltzmann Cluster Oncology, Vienna, Austria
Vol. 98 No. 9 (2013): September, 2013 https://doi.org/10.3324/haematol.2012.079202